Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Leetal Eliyahu, Zohar Yosibash, Irit Avivi, Yael C. Cohen, Gal Ariel, Ofer Sadovnic & Amir Sternheim. (2023) On the influence of computed tomography's slice thickness on computer tomography based finite element analyses results. Clinical Biomechanics 102, pages 105889.
Crossref
Crossref
Janik Engelmann, Jennifer Zarrer, Victoria Gensch, Kristoffer Riecken, Nikolaus Berenbrok, The Vinh Luu, Antonia Beitzen-Heineke, Maria Elena Vargas-Delgado, Klaus Pantel, Carsten Bokemeyer, Somasekhar Bhamidipati, Ihab S. Darwish, Esteban Masuda, Tal Burstyn-Cohen, Emily J. Alberto, Sourav Ghosh, Carla Rothlin, Eric Hesse, Hanna Taipaleenmäki, Isabel Ben-Batalla & Sonja Loges. (2022) Regulation of bone homeostasis by MERTK and TYRO3. Nature Communications 13:1.
Crossref
Crossref
Qian Li, Linhui Hu, Alice Charwudzi, Weiwei Zhu, Ye Meng & Zhimin Zhai. (2022) Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at diagnosis in untreated multiple myeloma patients: a systematic review and meta-analysis. Clinical and Experimental Medicine.
Crossref
Crossref
Massimo De Martinis, Alessandro Allegra, Maria Maddalena Sirufo, Alessandro Tonacci, Giovanni Pioggia, Martina Raggiunti, Lia Ginaldi & Sebastiano Gangemi. (2021) Vitamin D Deficiency, Osteoporosis and Effect on Autoimmune Diseases and Hematopoiesis: A Review. International Journal of Molecular Sciences 22:16, pages 8855.
Crossref
Crossref
Olga Pires, Ana Andrade Oliveira, Joana Morais & Maria João Regadas. (2021) Multiple myeloma: when radiography suggests diagnosis. BMJ Case Reports 14:4, pages e241990.
Crossref
Crossref
Philipp Fervers, Andreas Glauner, Roman Gertz, Philipp Täger, Jonathan Kottlors, David Maintz & Jan Borggrefe. (2021) Virtual calcium-suppression in dual energy computed tomography predicts metabolic activity of focal MM lesions as determined by fluorodeoxyglucose positron-emission-tomography. European Journal of Radiology 135, pages 109502.
Crossref
Crossref
Grace Lassiter, Cole Bergeron, Ryan Guedry, Julia Cucarola, Adam M. Kaye, Elyse M. Cornett, Alan D. Kaye, Giustino Varrassi, Omar Viswanath & Ivan Urits. (2021) Belantamab Mafodotin to Treat Multiple Myeloma: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. Current Oncology 28:1, pages 640-660.
Crossref
Crossref
Jake P. Taylor-King, Pascal R. Buenzli, S. Jon Chapman, Conor C. Lynch & David Basanta. (2020) Modeling Osteocyte Network Formation: Healthy and Cancerous Environments. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Smith Giri, Weiwei Zhu, Rong Wang, Amer Zeidan, Nikolai Podoltsev, Steven D. Gore, Natalia Neparidze, Xiaomei Ma, Cary P. Gross, Amy J. Davidoff & Scott F. Huntington. (2019) Underutilization of guideline‐recommended supportive care among older adults with multiple myeloma in the United States. Cancer 125:22, pages 4084-4095.
Crossref
Crossref
Sarah Anne Bird & Kevin Boyd. (2019) Multiple myeloma: an overview of management. Palliative Care and Social Practice 13, pages 117822421986823.
Crossref
Crossref
A. Hussain, R.J. Lee, J.N. Graff & S. Halabi. (2019) The evolution and understanding of skeletal complication endpoints in clinical trials of tumors with metastasis to the bone. Critical Reviews in Oncology/Hematology 139, pages 108-116.
Crossref
Crossref
Lei Wang, Munish Kumar, Qipan Deng, Xu Wang, Ming Liu, Zhaojian Gong, Shanshan Zhang, Xiaodong Ma, Zijun Y. Xu-Monette, Min Xiao, Qing Yi, Ken H. Young, Kenneth S. Ramos & Yong Li. (2019) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces peripheral blood abnormalities and plasma cell neoplasms resembling multiple myeloma in mice. Cancer Letters 440-441, pages 135-144.
Crossref
Crossref
Giuseppe Petralia & Anwar R. Padhani. (2018) Whole-Body Magnetic Resonance Imaging in Oncology. Magnetic Resonance Imaging Clinics of North America 26:4, pages 495-507.
Crossref
Crossref
Siyang Leng & Suzanne Lentzsch. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
743
751
.
Sigrun ThorsteinsdottirSigrun H. LundEbba K. LindqvistMarianna ThordardottirGunnar SigurdssonRene Costello, Debra Burton, Hlif SteingrimsdottirVilmundur GudnasonGudny EiriksdottirKristin SiggeirsdottirTamara B. Harris, Ola Landgren & Sigurdur Y. Kristinsson. (2017) Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study. Blood Advances 1:27, pages 2790-2798.
Crossref
Crossref
Nicholas Bingham, Antonia Reale & Andrew Spencer. (2017) An Evidence-Based Approach to Myeloma Bone Disease. Current Hematologic Malignancy Reports 12:2, pages 109-118.
Crossref
Crossref
X Leleu, C Kyriakou, I Vande Broek, P Murphy, P Bacon, P Lewis, H Gilet, B Arnould & M T Petrucci. (2017) Prospective longitudinal study on quality of life in relapsed/refractory multiple myeloma patients receiving second- or third-line lenalidomide or bortezomib treatment. Blood Cancer Journal 7:3, pages e543-e543.
Crossref
Crossref
Hui Liu, Fengping Peng, Zhaoyun Liu, Fengjuan Jiang, Lijuan Li, Shan Gao, Guojin Wang, Jia Song, Erbao Ruan, Zonghong Shao & Rong Fu. (2017) CYR61/CCN1 stimulates proliferation and differentiation of osteoblasts in vitro and contributes to bone remodelling in vivo in myeloma bone disease. International Journal of Oncology 50:2, pages 631-639.
Crossref
Crossref
Christina V. OlesonChristina V. Oleson. 2017. Osteoporosis Rehabilitation. Osteoporosis Rehabilitation
349
389
.
Liesbeth Bieghs, Hans E. Johnsen, Ken Maes, Eline Menu, Els Van Valckenborgh, Michael T. Overgaard, Mette Nyegaard, Cheryl A. Conover, Karin Vanderkerken & Elke De Bruyne. (2016) The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential. Oncotarget 7:30, pages 48732-48752.
Crossref
Crossref
Ravi Vij, Kathryn J. Fowler & Monica Shokeen. (2016) New Approaches to Molecular Imaging of Multiple Myeloma. Journal of Nuclear Medicine 57:1, pages 1-4.
Crossref
Crossref
Zhimin Gu, He Wang, Jiliang Xia, Ye Yang, Zhendong Jin, Hongwei Xu, Jumei Shi, Ivana De Domenico, Guido Tricot & Fenghuang Zhan. (2015) Decreased Ferroportin Promotes Myeloma Cell Growth and Osteoclast Differentiation. Cancer Research 75:11, pages 2211-2221.
Crossref
Crossref
Francesca Patriarca, Francesca Carobolante, Elena Zamagni, Vittorio Montefusco, Benedetto Bruno, Emanuaela Englaro, Cristina Nanni, Onelio Geatti, Miriam Isola, Alessandra Sperotto, Silvia Buttignol, Raffaella Stocchi, Paolo Corradini, Michele Cavo & Renato Fanin. (2015) The Role of Positron Emission Tomography with 18F-Fluorodeoxyglucose Integrated with Computed Tomography in the Evaluation of Patients with Multiple Myeloma Undergoing Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 21:6, pages 1068-1073.
Crossref
Crossref
Yaxia Zhang, Andrew E. Rosenberg, Lester J. Layfield & G. Petur Nielsen. 2015. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology
1008
1124
.
Sarah K. JohnsonJames P. StewartRakesh BamPingping Qu, Bart BarlogieFrits van RheeJohn D. ShaughnessyJrJr, Joshua EpsteinShmuel Yaccoby. (2014) CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease. Blood 124:13, pages 2051-2060.
Crossref
Crossref
Deepti Soodgupta, Michelle A. Hurchla, Majiong Jiang, Alexander Zheleznyak, Katherine N. Weilbaecher, Carolyn J. Anderson, Michael H. Tomasson & Monica Shokeen. (2013) Very Late Antigen-4 (α4β1 Integrin) Targeted PET Imaging of Multiple Myeloma. PLoS ONE 8:2, pages e55841.
Crossref
Crossref